The ADC binds HER2 (ERBB2), is internalized, and releases a topoisomerase I inhibitor that causes DNA damage and apoptosis. DNA topoisomerase I is the intracellular enzymatic target of the payload, not the binding/targeting antigen, so cells are not killed based on Topo I expression per se.